Pfizer Sells Capsugel And Lowers Expectations
The U.S. pharmaceutical giant Pfizer divests its non-core businesses and sells the world's largest pharmaceutical capsule producers Capsugel to the investment company KKR. The financial investor will pay about USD 2.4 billion for the company. At the same time, the company lowered its revenue forecast slightly. Pfizer had already announced in October that it plans to consider a separation of Capsugel. The Pfizer's daughter generated an annual turnover of around USD 750 million. In addition to hard capsules made of gelatin, the company sells softgel Capsules to different Pharmaceutical companies. Because of the separation, Pfizer lowered its sales targets for this and the next few years. Pfizer now expects sales for 2011 of USD 65.2 to 67.2 billion before USD 66-68 billion.
Pfizers stock price closed at USD 20.54. The current dividend yield of the company amounts to 3.9 percent while the P/E ratio amounts to 20.01. Here is a table of some drug manufacturing stocks with some fundamentals: http://t.co/iuVYYax
Since December 01, 2010, the stock price of PFE is still rising and gained by 22.9 percent. Do you believe that the company made a turn?